Levofloxacin Plus Metronidazole Administered Once Daily Versus Moxifloxacin Monotherapy Against a Mixed Infection of Escherichia Coli and Bacteroides Fragilis in an in Vitro Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.49.2.685-689.2005

Full Text

Abstract

Available in

Date

February 1, 2005

Authors

Publisher

American Society for Microbiology

Related search

In Vitro Activities of Levofloxacin, Gatifloxacin, Moxifloxacin and Garenoxacin Against Bacteroides Fragilis Strains Evaluated by Kill Kinetics

Journal of Medical Microbiology

Medicine

Microbiology

2013

English

Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin Against Streptococcus Pneumoniae in an in Vitro Model of Infection

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1999

English

Activity of Once-Daily Cefpodoxime Regimens Against Haemophilus Influenzae and Streptococcus Pneumoniae With an in Vitro Pharmacodynamic Chamber Model.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1996

English

In Vitro Activity of Trovafloxacin Against Bacteroides Fragilis in Mixed Culture With Either Escherichia Coli or a Vancomycin- Resistant Strain of Enterococcus Faecium Determined by an Anaerobic Time-Kill Technique

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2001

English

Expression of Bacteroides Fragilis Virulence Markers in Vitro

Journal of Medical Microbiology

Medicine

Microbiology

1999

English

Pharmacodynamics of Ampicillin-Sulbactam in an in Vitro Infection Model Against Escherichia Coli Strains With Various Levels of Resistance

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1998

English

Pharmacokinetic–Pharmacodynamic Modeling of Enrofloxacin Against Escherichia Coli in Broilers

Frontiers in Veterinary Science

Veterinary

2016

English

Bacteroides Fragilis Strain ZY-312 Defense Against Cronobacter Sakazakii-Induced Necrotizing Enterocolitis in Vitro and in a Neonatal Rat Model

Computer Science Applications

English

Single Dose Cefotaxime Plus Metronidazole Versus Three Dose Cefuroxime Plus Metronidazole as Prophylaxis Against Wound Infection in Colorectal Surgery: Multicentre Prospective Randomised Study.

BMJ

1990

English

Amanote Research

Levofloxacin Plus Metronidazole Administered Once Daily Versus Moxifloxacin Monotherapy Against a Mixed Infection of Escherichia Coli and Bacteroides Fragilis in an in Vitro Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

In Vitro Activities of Levofloxacin, Gatifloxacin, Moxifloxacin and Garenoxacin Against Bacteroides Fragilis Strains Evaluated by Kill Kinetics

Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin Against Streptococcus Pneumoniae in an in Vitro Model of Infection

Activity of Once-Daily Cefpodoxime Regimens Against Haemophilus Influenzae and Streptococcus Pneumoniae With an in Vitro Pharmacodynamic Chamber Model.

In Vitro Activity of Trovafloxacin Against Bacteroides Fragilis in Mixed Culture With Either Escherichia Coli or a Vancomycin- Resistant Strain of Enterococcus Faecium Determined by an Anaerobic Time-Kill Technique

Expression of Bacteroides Fragilis Virulence Markers in Vitro

Pharmacodynamics of Ampicillin-Sulbactam in an in Vitro Infection Model Against Escherichia Coli Strains With Various Levels of Resistance

Pharmacokinetic–Pharmacodynamic Modeling of Enrofloxacin Against Escherichia Coli in Broilers

Bacteroides Fragilis Strain ZY-312 Defense Against Cronobacter Sakazakii-Induced Necrotizing Enterocolitis in Vitro and in a Neonatal Rat Model

Single Dose Cefotaxime Plus Metronidazole Versus Three Dose Cefuroxime Plus Metronidazole as Prophylaxis Against Wound Infection in Colorectal Surgery: Multicentre Prospective Randomised Study.